| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,562,000 | 5,292,800 | 5,047,000 | 5,210,500 | | Cost of Revenue | 1,051,900 | 947,400 | 816,400 | 915,400 | | | Gross Profit | 4,510,100 | 4,345,400 | 4,230,600 | 4,295,100 | | | Operating Expenses | | Research Development | 1,122,100 | 1,040,400 | 947,300 | 1,059,300 | | Selling General and Administrative | 1,701,800 | 1,708,200 | 1,529,200 | 1,726,600 | | Non Recurring | 549,800 | 105,000 |
-
| 4,765,400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,136,400 | 1,491,800 | 1,754,100 | (3,256,200) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,700) | 40,200 | 16,900 | 700 | | Earnings Before Interest And Taxes | 1,128,700 | 1,532,000 | 1,771,000 | (3,255,500) | | Interest Expense | 59,200 | 64,300 | 87,600 | 81,900 | | Income Before Tax | 1,069,500 | 1,467,700 | 1,683,400 | (3,337,400) | | Income Tax Expense | 127,700 | 309,200 | 370,300 | 292,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 941,800 | 1,158,500 | 1,313,100 | (3,629,400) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 941,800 | 1,158,500 | 1,313,100 | (3,629,400) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $941,800 | $1,158,500 | $1,313,100 | ($3,629,400) |
|
0.03% Nasdaq 
Income Statement
